Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

['Fatigue' in multiple sclerosis].

C Zimmermann1, R Hohlfeld

  • 1Neurologische Klinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, München.

Der Nervenarzt
|July 21, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A taxonomy of the factors contributing to the overtreatment of cancer patients at the end of life. What is the problem? Why does it happen? How can it be addressed?

ESMO open·2025
Same author

Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.

ESMO open·2021
Same author

Supersolid Properties of a Bose-Einstein Condensate in a Ring Resonator.

Physical review letters·2020
Same author

Fast In Situ Observation of Atomic Feshbach Resonances by Photoassociative Ionization.

Physical review letters·2020
Same author

Study of <math></math> and <math></math> production in <math></math> collisions at <math> </math> and search for anomalous quartic gauge couplings with the ATLAS experiment.

The European physical journal. C, Particles and fields·2020
Same author

Identification and rejection of pile-up jets at high pseudorapidity with the ATLAS detector.

The European physical journal. C, Particles and fields·2020
Same journal

[Digital health applications and adherence in depression: a qualitative study from the perspective of healthcare providers].

Der Nervenarzt·2026
Same journal

[Pathological hoarding-A review of the disorder].

Der Nervenarzt·2026
Same journal

[Late-onset manifestation of Tay-Sachs disease-A disease of the cerebellum and motor neurons with psychiatric sequelae].

Der Nervenarzt·2026
Same journal

[Neuropsychiatric manifestations of sex chromosome aberrations-Clinical and therapeutic aspects of neuropsychiatric care].

Der Nervenarzt·2026
Same journal

[Associations Between Genetic Causes of Psychiatric Disorders and Rare Monogenic Epilepsies].

Der Nervenarzt·2026
Same journal

[From the diagnostic category "mental deficiency" (ICD-6) to the diagnostic category "disorder of intellectual development" (ICD-11)].

Der Nervenarzt·2026
See all related articles

Fatigue significantly impacts multiple sclerosis patients

Area of Science:

  • Neurology
  • Neuroimmunology

Context:

  • Multiple sclerosis (MS) is a chronic neurological disease.
  • Fatigue is a prevalent and debilitating symptom in MS patients.
  • Current understanding of MS fatigue pathophysiology remains limited.

Purpose:

  • To explore the potential therapeutic benefits of aminopyridines for managing fatigue in multiple sclerosis.
  • To investigate the mechanisms by which aminopyridines may alleviate MS-related fatigue.

Summary:

  • Fatigue, characterized by rapid exhaustion and reduced exercise tolerance, severely affects daily life for individuals with multiple sclerosis.
  • While the exact causes of MS fatigue are unknown, potential factors include neuroanatomic damage or central nervous system inflammation.
  • Aminopyridines, such as 4-aminopyridine and 3,4-diaminopyridine, are emerging as therapeutic options, potentially enhancing nerve conduction and central stimulation.

Related Experiment Videos

Impact:

  • Aminopyridine treatment may offer a novel approach to managing debilitating fatigue in multiple sclerosis.
  • Further research is needed to fully elucidate the efficacy and safety profile of aminopyridines in MS fatigue.
  • Understanding the mechanisms of action could lead to more targeted and effective fatigue management strategies for MS patients.